"Meritus Medical Center is an acute care hospital located in Hagerstown, Maryland with 247 beds, along with the most advanced technologies available. Services include a special care nursery, a level III trauma program, a primary stroke center, and a wound center, as well as a cardiac diagnostic laboratory. Other hospital services that address outpatient needs are the John R. Marsh Cancer Center, Total Rehab Care, the Center for Clinical Research, and the Center for Bariatric Surgery. State-of-the-art medical technologies at Meritus Medical Center include advanced 3T magnetic resonance imaging (MRI), single-photo-emission computed tomography (SPECT) scanners, and cardiac interventions."

During the past decade, Meritus Center For Clinical Research conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 15 clinical trials were completed, i.e. on average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Meritus Center For Clinical Research" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Exact Sciences Corporation" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored and "Allergan" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Meritus Center For Clinical Research" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "Galapagos NV" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Meritus Center For Clinical Research" are "Nonalcoholic Steatohepatitis" (3 trials), "Ulcerative Colitis" (3 trials), "Breast Cancer" (2 trials), "Crohn's Disease" (2 trials) and "Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Meritus Center For Clinical Research" in a lesser frequency.

Most popular intervention types in "Meritus Center For Clinical Research" are "Drug" (26 trials), "Other" (5 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Filgotinib" (5 trials), "Blood Sample Collection" (2 trials), "Carboplatin" (2 trials) and "Linaclotide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Meritus Center For Clinical Research" are 31 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Meritus Center For Clinical Research". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Meritus Center For Clinical Research, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Meritus Center For Clinical Research, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".